Piermont Capital Management Inc. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 162 filers reported holding HAEMONETICS CORP in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Piermont Capital Management Inc. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2018$4,052,000
+0.1%
45,187
-18.4%
1.24%
-8.2%
Q1 2018$4,049,000
+28.9%
55,347
+2.3%
1.35%
+31.0%
Q4 2017$3,142,000
+25.4%
54,097
-3.1%
1.03%
+24.2%
Q3 2017$2,506,000
+13.7%
55,8470.0%0.83%
+31.5%
Q2 2017$2,205,000
-22.7%
55,847
-20.6%
0.63%
-7.2%
Q1 2017$2,853,000
-8.2%
70,317
-9.1%
0.68%
-4.2%
Q4 2016$3,108,000
+3.1%
77,317
-7.1%
0.71%
-0.4%
Q3 2016$3,014,000
+23.0%
83,237
-1.5%
0.71%
+12.5%
Q2 2016$2,450,000
-17.1%
84,4970.0%0.63%
-32.8%
Q1 2016$2,956,000
+5.9%
84,497
-2.4%
0.94%
+6.3%
Q4 2015$2,791,00086,5570.89%
Other shareholders
HAEMONETICS CORP shareholders Q4 2015
NameSharesValueWeighting ↓
Bridge City Capital, LLC 40,541$5,114,0002.20%
Lisanti Capital Growth, LLC 53,385$6,734,0002.20%
Nitorum Capital, L.P. 279,510$35,257,0002.05%
CROWN ADVISORS MANAGEMENT, INC. 20,000$2,523,0001.69%
Millrace Asset Group, Inc. 11,400$1,438,0001.69%
COOKSON PEIRCE & CO INC 145,884$18,402,0001.61%
Endurant Capital Management LP 32,594$4,111,0001.48%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 111,000$14,002,0001.38%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 110,065$13,884,0001.37%
EMERALD ADVISERS, LLC 203,640$25,687,0001.20%
View complete list of HAEMONETICS CORP shareholders